Yüklüyor......
Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients: A Systematic Review and Meta-regression
BACKGROUND: This meta-analysis was to determine the association of the cumulative dose of 130/0.4 or 0.42 (hydroxyethyl starch [HES] 130/0.4*) or delta daily fluid balance (i.e., daily fluid balance in HES group over or below control group) with the heterogeneity of risk ratio (RR) for mortality in...
Kaydedildi:
Yayımlandı: | Chin Med J (Engl) |
---|---|
Asıl Yazarlar: | , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2015
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733795/ https://ncbi.nlm.nih.gov/pubmed/26315087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.163387 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|